Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum

Key facts

Sponsor

Assistance Publique Hopitaux De Marseille

Principal Investigator

EMILIE GARRIDO PRADALIE

APHM

Intervention

pathology associated(other)

Enrollment

140 enrolled

Eligibility

All sexes

Timeline

2018 – 2019

Study locations (1)

• Assistance Publique Des Hopitaux de Marseille, Marseille, PACA, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Classic pyoderma gangrenosum

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT06624670
  A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
  Boehringer Ingelheim
• RECRUITINGPHASE2NCT06563323
  Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
  Oregon Health and Science University

See all trials for Classic pyoderma gangrenosum →